BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29179503)

  • 1. Can polysaccharide K improve therapeutic efficacy and safety in gastrointestinal cancer? a systematic review and network meta-analysis.
    Ma Y; Wu X; Yu J; Zhu J; Pen X; Meng X
    Oncotarget; 2017 Oct; 8(51):89108-89118. PubMed ID: 29179503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polysaccharide K and Coriolus versicolor extracts for lung cancer: a systematic review.
    Fritz H; Kennedy DA; Ishii M; Fergusson D; Fernandes R; Cooley K; Seely D
    Integr Cancer Ther; 2015 May; 14(3):201-11. PubMed ID: 25784670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical application of honey in the management of chemo/radiotherapy-induced oral mucositis: A systematic review and network meta-analysis.
    Yang C; Gong G; Jin E; Han X; Zhuo Y; Yang S; Song B; Zhang Y; Piao C
    Int J Nurs Stud; 2019 Jan; 89():80-87. PubMed ID: 30352321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of polysaccharides from Auricularia auricula (Huaier) in adjuvant anti-gastrointestinal cancer therapy: A systematic review and network meta-analysis.
    Ma Y; Wang C; Zhang Q; Peng X; Feng Y; Meng X
    Pharmacol Res; 2018 Jun; 132():80-89. PubMed ID: 29673791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials.
    Sakamoto J; Morita S; Oba K; Matsui T; Kobayashi M; Nakazato H; Ohashi Y;
    Cancer Immunol Immunother; 2006 Apr; 55(4):404-11. PubMed ID: 16133112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the best combination treatment with transarterial chemoembolization of unresectable hepatocellular carcinoma? a systematic review and network meta-analysis.
    Xie H; Yu H; Tian S; Yang X; Wang X; Yang Z; Wang H; Guo Z
    Oncotarget; 2017 Nov; 8(59):100508-100523. PubMed ID: 29245997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I.
    Ito G; Tanaka H; Ohira M; Yoshii M; Muguruma K; Kubo N; Yashiro M; Yamada N; Maeda K; Sawada T; Hirakawa K
    Exp Ther Med; 2012 Jun; 3(6):925-930. PubMed ID: 22969994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study.
    Ohwada S; Ikeya T; Yokomori T; Kusaba T; Roppongi T; Takahashi T; Nakamura S; Kakinuma S; Iwazaki S; Ishikawa H; Kawate S; Nakajima T; Morishita Y
    Br J Cancer; 2004 Mar; 90(5):1003-10. PubMed ID: 14997197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative CEA and PPD values as prognostic factors for immunochemotherapy using PSK and 5-FU.
    Takahashi Y; Mai M; Nakazato H
    Anticancer Res; 2005; 25(2B):1377-84. PubMed ID: 15865094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III trial comparing UFT + PSK to UFT + LV in stage IIB, III colorectal cancer (MCSGO-CCTG).
    Miyake Y; Nishimura J; Kato T; Ikeda M; Tsujie M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M;
    Surg Today; 2018 Jan; 48(1):66-72. PubMed ID: 28634730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic markers for immunochemotherapy using tegafur -uracil (UFT) and protein-bound polysaccharide K (PSK).
    Yoshinaga K; Saeki H; Oki E; Morita M; Ikeda T; Sugimachi K; Yamashita Y; Ikegami T; Uchiyama H; Yoshizumi T; Soejima Y; Kawanaka H; Mimori K; Watanabe M; Maehara Y
    Fukuoka Igaku Zasshi; 2013 Dec; 104(12):549-58. PubMed ID: 24693683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
    Fisher M; Yang LX
    Anticancer Res; 2002; 22(3):1737-54. PubMed ID: 12168863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSK may suppress CD57(+) T cells to improve survival of advanced gastric cancer patients.
    Akagi J; Baba H
    Int J Clin Oncol; 2010 Apr; 15(2):145-52. PubMed ID: 20229169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker.
    Kudo S; Tanaka J; Kashida H; Tamegai Y; Endo S; Yamano HO
    Oncol Rep; 2002; 9(3):635-8. PubMed ID: 11956642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA antigen as predictive index for the outcome of breast cancer patients with adjuvant immunochemotherapy with PSK.
    Yokoe T; Iino Y; Takei H; Horiguchi J; Koibuchi Y; Maemura M; Ohwada S; Morishita Y
    Anticancer Res; 1997; 17(4A):2815-8. PubMed ID: 9252721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemotherapy benefits in gastric cancer patients stratified by programmed death-1 ligand-1.
    Hsu JT; Hsu CS; Le PH; Chen TC; Chou WC; Lin CY; Yeh TS
    J Surg Res; 2017 May; 211():30-38. PubMed ID: 28501128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of adjuvant immunochemotherapy in advanced gastric cancer].
    Sakamoto J; Nakazato H
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2525-30. PubMed ID: 8279851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer.
    Tanaka H; Muguruma K; Ohira M; Kubo N; Yamashita Y; Maeda K; Sawada T; Hirakawa K
    Anticancer Res; 2012 Aug; 32(8):3427-33. PubMed ID: 22843926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of protein-bound polysaccharide K in patients with gastric cancer undergoing chemotherapy with an oral fluoropyrimidine (S-1).
    Namikawa T; Fukudome I; Ogawa M; Munekage E; Munekage M; Shiga M; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
    Eur J Surg Oncol; 2015 Jun; 41(6):795-800. PubMed ID: 25887287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An effect of adjuvant immunochemotherapy using krestin and 5-FU on gastric cancer patients with radical surgery (first report)--a randomized controlled trial by the cooperative study group. Study Group of Immuno-chemotherapy with PSK for Gastric Cancer].
    Nakazato H; Koike A; Ichihashi H; Saji S; Danno M; Ogawa N
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2563-76. PubMed ID: 2505682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.